RIBOMAB
LIVE

Serial Number

79218814

Owner

BioNTech SE

Filing Date

Aug 22, 2017

Add to watchlist:

No watchlists yet
View on USPTO

RIBOMAB Trademark

Serial Number: 79218814 • Registration: 5510495

RIBOMAB is a trademark filed by BioNTech SE on August 22, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

BioNTech RNA Pharmaceuticals GmbH

An der Goldgrube 12

Entity Type: 27

Trademark Details

Filing Date

August 22, 2017

Registration Date

July 10, 2018

Published for Opposition

April 24, 2018

Cancellation Date

January 24, 2025

Goods & Services

Scientific research for medical and veterinary purposes, in particular in respect of approaches for treating cancerous diseases, infections, autoimmune disorders and metabolic disorders

Medical and veterinary services in connection with the treatment of cancerous diseases, infections, autoimmune disorders and metabolic disorders

Pharmaceuticals and veterinary preparations, of all kinds, namely, pharmaceuticals and veterinary preparations for treating cancerous diseases, infections, autoimmune disorders and metabolic disorders; diagnostic preparations for the detection of cancerous diseases, infections, autoimmune disorders and metabolic disorders

Treatment of materials and material conversion, namely, custom manufacture of chemicals and biochemical substances; custom manufacture of chemicals and biochemical substances; custom manufacture of therapeutic preparations for the treatment of cancerous diseases, infections, autoimmune disorders and metabolic disorders

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 12, 2026 NREP
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 11, 2026 INTS
INVALIDATION PROCESSED
Mar 11, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 24, 2025 INTR
CANCELLED SECTION 71
Jan 24, 2025 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Apr 15, 2022 NREP
CHANGE OF OWNER RECEIVED FROM IB
Dec 31, 2021 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 9, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 22, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 22, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 10, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 10, 2018 R.PR
PUBLISHED FOR OPPOSITION
Apr 24, 2018 PUBO
NOTICE OF PUBLICATION
Apr 4, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 20, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2018 CRFA
ASSIGNED TO LIE
Mar 9, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2018 TROA
REFUSAL PROCESSED BY IB
Jan 27, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 8, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jan 8, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 19, 2017 RFCR
NON-FINAL ACTION WRITTEN
Dec 18, 2017 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Dec 14, 2017 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 5, 2017 RFCR
NON-FINAL ACTION WRITTEN
Dec 4, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 27, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 27, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 23, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR